Words for clinical notes
Search 5,131 terms by clinical wording, everyday description, or note example.
| Word | Plain-English search cue | Original note example | SOAP section | Writing task |
|---|---|---|---|---|
dose-normalized peak | peak concentration divided by the dose used for that observation | The dose-normalized peak was interpreted with the formulation and sampling window. | Assessment | Drug concentrations, exposure and assay interpretation |
dose-normalized trough | trough concentration divided by a defined dose metric | Dose-normalized trough was compared only across samples with confirmed predose timing. | Assessment | Medication response, exposure and reconciliation |
formation-limited kinetics | metabolite concentration profile is governed substantially by its rate of formation | Formation-limited kinetics was considered in interpreting the parent-metabolite sequence. | Assessment | Medication response, exposure and reconciliation |
glucosuria threshold | blood glucose concentration at which glucose begins appearing in urine under the stated conditions | The glucosuria threshold was discussed in light of the current medication. | Objective | Glucose monitoring, endocrine testing and urine studies |
half-life | time for concentration to fall by half during a specified elimination phase | The estimated half-life reflects the sampling period used in the model. | Assessment | Drug levels - exposure and pharmacokinetics |
| oxygen-carrying protein concentration reported in blood | The hemoglobin decreased by 1.2 g/dL since admission. | Objective | Hematology, coagulation and transfusion observations | |
hyperosmolar state | increased concentration of dissolved particles in body fluid, interpreted with effective solutes specified | Hyperosmolar state was characterized with glucose, sodium and measured osmolality. | Assessment | Acid-base and electrolyte interpretation |
ionized hypocalcemia | low concentration of biologically active calcium | Ionized hypocalcemia was confirmed on the ionized calcium measurement. | Assessment | Acid-base and electrolyte interpretation |
lamotrigine | antiseizure medicine for which a concentration may be compared with an individual baseline | The lamotrigine result is listed with the patient's earlier stable value. | Objective | Drug levels - named analytes and exposure reports |
linear kinetics | concentration or exposure changes proportionally with dose under stated conditions | The dosing model assumes linear kinetics over the range examined. | Assessment | Drug levels - exposure and pharmacokinetics |
lithium | mood stabilizer measured with a timed blood concentration | The lithium level is documented with the evening dose and morning draw times. | Objective | Drug levels - named analytes and exposure reports |
mistimed level | concentration drawn outside the intended window | Document the mistimed level with its actual collection time. | Plan | Drug levels - verification and documentation |
morning cortisol | cortisol concentration from a sample collected in the morning | Morning cortisol was documented with the exact clock time and steroid exposure. | Objective | Glucose monitoring, endocrine testing and urine studies |
osmotic | related to movement of water across a concentration gradient | The history raises the possibility of an osmotic contribution to the diarrhea. | Assessment | Mechanisms and localization |
paired levels | two concentrations interpreted together with their timing | The paired levels were collected during the same dosing interval. | Objective | Drug levels - collection and dose timing |
paired peak and trough | two concentrations intended to represent different points of one dosing interval | Paired peak and trough were interpreted after confirming both belonged to the same interval. | Assessment | Medication response, exposure and reconciliation |
parent-to-metabolite ratio | parent drug concentration divided by the measured metabolite concentration | The parent-to-metabolite ratio was recorded with both analytes and collection times. | Assessment | Medication response, exposure and reconciliation |
partial AUC | area under the concentration-time curve over a defined subinterval | The partial AUC was reported for the first four hours with the interval specified. | Assessment | Drug concentrations, exposure and assay interpretation |
| highest concentration in a dosing interval, or a sample intended to estimate it | The specimen labeled peak was drawn 45 minutes after the documented end of infusion. | Objective | Drug levels - collection and dose timing | |
peak-to-trough fluctuation | extent of change between highest and lowest concentrations across a dosing interval | The report defines the calculation used for peak-to-trough fluctuation. | Assessment | Drug concentrations, exposure and assay interpretation |
peak-to-trough ratio | peak concentration divided by trough concentration for the stated interval | The peak-to-trough ratio uses two results from the same dosing interval. | Assessment | Drug concentrations, exposure and assay interpretation |
pharmacodynamic interaction | combined drug effects without necessarily changing concentration | The review considers a pharmacodynamic interaction as a contributor to sedation. | Assessment | Medication exposure, response and adverse-effect reasoning |
phenobarbital | barbiturate whose blood concentration may be monitored | The phenobarbital sample time is recorded after the most recent administration. | Objective | Drug levels - named analytes and exposure reports |
posaconazole | azole antifungal whose formulation and timing matter for concentration review | The posaconazole report is filed with the formulation recorded in pharmacy history. | Objective | Drug levels - named analytes and exposure reports |
post-hold level | drug concentration measured after therapy was held | The post-hold level was recorded with the time elapsed since the last confirmed dose. | Assessment | Medication response, exposure and reconciliation |